AYTU
(NASDAQ)
1.81
+0.2377  (+13.13%)
Volume (24h): 23.43M Day Range: 1.66 - 1.86
Market Cap: 141.93M 52W Range: 0.3352 - 2.99
Mar-25-20 01:08PM Aytu BioScience (AYTU) in Focus: Stock Moves 6.4% HigherZacks
12:00PM Aytu BioScience Regains Compliance with NASDAQ Minimum Bid Price RequirementACCESSWIRE
Mar-24-20 05:15PM Aytu BioScience to Issue Coronavirus Rapid Test in North AmericaZacks
11:43AM The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-DiagnosticsZacks
Mar-23-20 01:48PM FDA Gives Aytu OK To Distribute Rapid COVID-19 Test, Company Expects To Receive 100,000 Tests This WeekBenzinga
12:00PM Aytu BioScience Submits Notice of Commercialization to the FDA, Allowing for Company's Distribution of its 2-10 Minute COVID-19 IgG/IgM Point-of-Care Rapid TestACCESSWIRE
Mar-19-20 04:40PM Aytu Announces $20 Million Registered Direct Offering Priced At-the-MarketACCESSWIRE
12:00PM Aytu BioScience Expands Its Distribution Rights for Coronavirus 2019 (COVID-19) Point-of-Care Rapid Test to Canada and MexicoACCESSWIRE
Mar-17-20 03:55PM Aytu BioScience Announces Acceleration of U.S. Availability of COVID-19 IgG/IgM Rapid Test Based on Updated FDA PolicyACCESSWIRE
Mar-16-20 04:00PM Aytu BioScience's Coronavirus Rapid Test Featured on NBC and Fox News (VIDEOS): ''Englewood Company Says It Can Get COVID-19 Test Results in 2-10 Minutes"; "2-Minute COVID-19 Test Results? Denver-Area Company Wants to Deliver That Promise"ACCESSWIRE
Mar-13-20 02:53PM The Latest Coronavirus Developments From Biotechs: La Jolla Provides Giapreza In Italy, Enanta Researches AntiviralsBenzinga
12:00PM Aytu BioScience Establishes COVID-19 IgG/IgM Rapid Test Product Inquiry Procedure for Healthcare Professionals and InstitutionsACCESSWIRE
Mar-12-20 03:30PM Has Aytu Bioscience (AYTU) Outpaced Other Medical Stocks This Year?Zacks
12:00PM Aytu Announces $20 Million Registered Direct Offering Priced At-the-MarketACCESSWIRE
Mar-11-20 12:52PM Aytu BioScience, Inc. (AYTU) Shares March Higher, Can It Continue?Zacks
12:26PM Benzinga Pro's Top 5 Stocks To Watch For Wed., Mar. 11, 2020: TDOC, GNMK, HLT, MEET, AYTUBenzinga
Mar-11-20 12:03PM The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 TreatmentBenzinga
12:00PM Wall Street Rises on Trump's Stimulus: ETF & Stock GainersZacks
Mar-11-20 12:00PM Aytu Announces $9.0 Million Registered Direct Offering Priced At-the-MarketACCESSWIRE
Mar-10-20 12:05PM Aytu BioScience Secures Exclusive U.S. Distribution Agreement for Coronavirus 2019 (COVID-19) Point-of-Care Rapid TestACCESSWIRE
Mar-05-20 01:53AM Edited Transcript of AYTU earnings conference call or presentation 13-Feb-20 9:30pm GMTThomson Reuters StreetEvents
Mar-04-20 07:24PM Edited Transcript of AYTU earnings conference call or presentation 13-Feb-20 9:30pm GMTThomson Reuters StreetEvents
Feb-19-20 05:00PM All You Need to Know About Aytu Bioscience, Inc. (AYTU) Rating Upgrade to BuyZacks
Feb-18-20 02:00PM Aytu BioScience Completes Acquisition of Innovus PharmaceuticalsACCESSWIRE
Feb-13-20 09:10PM Aytu Reports Q2 Revenue of $3.2M, Up 77% Year-over-Year and 121% SequentiallyACCESSWIRE
Feb-06-20 02:00PM Aytu BioScience to Report Fiscal Q2 FY 2020 Results and Business UpdateACCESSWIRE
Feb-05-20 02:00PM Aytu BioScience Announces Acceptance of Results of Two Natesto Clinical Studies for Presentation at American Urological Association Annual Scientific ProgramACCESSWIRE
Jan-30-20 05:31PM Aytu Bioscience, Inc. (AYTU) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks
Jan-28-20 02:00PM Aytu BioScience Announces Acceptance of Natesto Spermatogenesis Study Results for Presentation at ENDO 2020ACCESSWIRE
Jan-27-20 02:00PM Aytu BioScience and Innovus Pharmaceuticals Announce Effectiveness of Form S-4 Registration Statement Related to Proposed Acquisition of Innovus by Aytu BioScienceACCESSWIRE
Dec-24-19 01:05PM Aytu BioScience and Innovus Pharmaceuticals Announce Filing of Form S-4 Registration Statement Related to Proposed Acquisition of Innovus by Aytu BioScienceACCESSWIRE
Dec-21-19 08:43PM Hedge Funds Are Warming Up To Aytu BioScience, Inc. (AYTU)Insider Monkey
Dec-18-19 04:30AM Rigrodsky & Long, P.A. Files Class Action Suit Against Aytu BioScience, Inc.GlobeNewswire
Dec-14-19 02:12PM INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Following TransactionACCESSWIRE
Dec-13-19 02:50PM CERC: Expansion in Rare and Orphan Diseases with Acquisition of Aevi Genomic Medicine…Zacks Small Cap Research
Dec-12-19 06:19PM SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of the Following MergersGlobeNewswire
02:13PM SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation Regarding the November 21, 2019 Preliminary Proxy Statement of AYTU BIOSCIENCE, INC. - AYTUPR Newswire
Dec-06-19 02:42AM Edited Transcript of AYTU earnings conference call or presentation 14-Nov-19 9:30pm GMTThomson Reuters StreetEvents
Dec-05-19 09:45PM Edited Transcript of AYTU earnings conference call or presentation 14-Nov-19 9:30pm GMTThomson Reuters StreetEvents
11:05AM MiOXSYS Male Infertility Test Will be Featured in Product Symposium at the 8th Annual Congress of the German Federation of Reproductive Biology and MedicineACCESSWIRE
Dec-03-19 01:05PM Aytu BioScience to Present at LD Micro 12th Annual Main Event Investor Conference on December 11, 2019ACCESSWIRE
Dec-02-19 01:05PM Aytu BioScience Announces Launch of Natesto(R) U.S. Co-Promotion with Acerus PharmaceuticalsACCESSWIRE
Nov-23-19 12:47PM Edited Transcript of AYTU earnings conference call or presentation 14-Nov-19 9:30pm GMTThomson Reuters StreetEvents
Nov-22-19 08:08PM Edited Transcript of AYTU earnings conference call or presentation 14-Nov-19 9:30pm GMTThomson Reuters StreetEvents
Nov-19-19 01:00PM Aytu BioScience Announces Addition of Tuzistra(R) XR to Leading Pharmacy Benefit Manager’s National FormularyACCESSWIRE
Nov-15-19 12:05AM Aytu Bioscience, Inc. (AYTU) Reports Q1 Loss, Lags Revenue EstimatesZacks
Nov-14-19 09:01PM Aytu Reports First Quarter 2020 Financial ResultsACCESSWIRE
Nov-11-19 11:05AM Aytu BioScience Announces Hiring of Matthew Phillips as Executive Vice President of Commercial OperationsACCESSWIRE
Nov-07-19 01:05PM Aytu BioScience to Report Fiscal Q1 FY 2020 Results and Business UpdateACCESSWIRE
Nov-04-19 07:15PM Kaskela Law LLC Announces Stockholder Investigation of Aytu BioScience, Inc. – AYTUGlobeNewswire
Aytu BioScience, Inc., a specialty healthcare company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and ZolpiMist, an oral spray for the treatment of insomnia. It also offers MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. In addition, the company provides MiOXSYS analyzer, a portable lightweight desktop platform that is used in clinical or research laboratory or near a patient care area; and MiOXSYS disposable sensors. The company is based in Englewood, Colorado.
Stocks in other countries: United Kingdom India Canada Australia
Market Cap
Volume (24h)